Page last updated: 2024-12-09

N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID655941
CHEMBL ID1521901
CHEBI ID120064

Synonyms (17)

Synonym
n-(3,4-dimethyl-phenyl)-2-[5-(4,6-dimethyl-pyrimidin-2-ylsulfanylmethyl)-4-furan-2-ylmethyl-4h-[1,2,4]triazol-3-ylsulfanyl]-acetamide
smr000001842
ASN 02833901 ,
MLS000889747
MLS000031951 ,
CHEBI:120064
AKOS000718496
n-(3,4-dimethylphenyl)-2-[[5-[(4,6-dimethylpyrimidin-2-yl)sulfanylmethyl]-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide
HMS2359E13
n-(3,4-dimethylphenyl)-2-[[5-[(4,6-dimethylpyrimidin-2-yl)sulfanylmethyl]-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]ethanamide
n-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethylpyrimidin-2-yl)thio]methyl]-4-(2-furfuryl)-1,2,4-triazol-3-yl]thio]acetamide
cid_655941
n-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide
bdbm76859
REGID_FOR_CID_655941
CHEMBL1521901
Q27207868
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anilideAny aromatic amide obtained by acylation of aniline.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency31.62280.044717.8581100.0000AID485341
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency50.11870.631035.7641100.0000AID504339
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
phosphopantetheinyl transferaseBacillus subtilisPotency25.11890.141337.9142100.0000AID1490
ATAD5 protein, partialHomo sapiens (human)Potency18.61740.004110.890331.5287AID504466; AID504467
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686978
thioredoxin glutathione reductaseSchistosoma mansoniPotency3.16230.100022.9075100.0000AID485364
67.9K proteinVaccinia virusPotency31.62280.00018.4406100.0000AID720579
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency0.79430.035520.977089.1251AID504332
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency25.11890.316212.443531.6228AID902
chromobox protein homolog 1Homo sapiens (human)Potency35.48130.006026.168889.1251AID540317
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency12.58930.65619.452025.1189AID927
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency39.81070.00419.962528.1838AID2675
neuropeptide S receptor isoform AHomo sapiens (human)Potency12.58930.015812.3113615.5000AID1461
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)Potency12.58931.584913.004325.1189AID927
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Annexin A2Homo sapiens (human)IC50 (µMol)9.77509.54999.775010.0000AID1162040
Protein S100-A10Homo sapiens (human)IC50 (µMol)9.77509.54999.775010.0000AID1162040
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
voltage-dependent T-type calcium channel subunit alpha-1H isoform aHomo sapiens (human)EC50 (µMol)4.05000.43404.827513.3000AID489005
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (70)

Processvia Protein(s)Taxonomy
angiogenesisAnnexin A2Homo sapiens (human)
membrane raft assemblyAnnexin A2Homo sapiens (human)
positive regulation of receptor recyclingAnnexin A2Homo sapiens (human)
negative regulation of receptor internalizationAnnexin A2Homo sapiens (human)
vesicle budding from membraneAnnexin A2Homo sapiens (human)
cell-matrix adhesionAnnexin A2Homo sapiens (human)
positive regulation of plasminogen activationAnnexin A2Homo sapiens (human)
response to activityAnnexin A2Homo sapiens (human)
collagen fibril organizationAnnexin A2Homo sapiens (human)
lung developmentAnnexin A2Homo sapiens (human)
positive regulation of vesicle fusionAnnexin A2Homo sapiens (human)
negative regulation of low-density lipoprotein particle receptor catabolic processAnnexin A2Homo sapiens (human)
osteoclast developmentAnnexin A2Homo sapiens (human)
fibrinolysisAnnexin A2Homo sapiens (human)
mRNA transcription by RNA polymerase IIAnnexin A2Homo sapiens (human)
positive regulation of vacuole organizationAnnexin A2Homo sapiens (human)
positive regulation of exocytosisAnnexin A2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIAnnexin A2Homo sapiens (human)
regulation of neurogenesisAnnexin A2Homo sapiens (human)
cell-cell adhesionAnnexin A2Homo sapiens (human)
epithelial cell apoptotic processAnnexin A2Homo sapiens (human)
positive regulation of low-density lipoprotein particle clearanceAnnexin A2Homo sapiens (human)
positive regulation of low-density lipoprotein particle receptor bindingAnnexin A2Homo sapiens (human)
positive regulation of low-density lipoprotein receptor activityAnnexin A2Homo sapiens (human)
positive regulation of receptor-mediated endocytosis involved in cholesterol transportAnnexin A2Homo sapiens (human)
positive regulation of plasma membrane repairAnnexin A2Homo sapiens (human)
membrane raft assemblyProtein S100-A10Homo sapiens (human)
vesicle budding from membraneProtein S100-A10Homo sapiens (human)
positive regulation of plasminogen activationProtein S100-A10Homo sapiens (human)
mRNA transcription by RNA polymerase IIProtein S100-A10Homo sapiens (human)
positive regulation of GTPase activityProtein S100-A10Homo sapiens (human)
positive regulation of exocytosisProtein S100-A10Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIProtein S100-A10Homo sapiens (human)
regulation of neurogenesisProtein S100-A10Homo sapiens (human)
positive regulation of stress fiber assemblyProtein S100-A10Homo sapiens (human)
positive regulation of focal adhesion assemblyProtein S100-A10Homo sapiens (human)
protein localization to plasma membraneProtein S100-A10Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingProtein S100-A10Homo sapiens (human)
positive regulation of plasma membrane repairProtein S100-A10Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
protease bindingAnnexin A2Homo sapiens (human)
RNA bindingAnnexin A2Homo sapiens (human)
serine-type endopeptidase inhibitor activityAnnexin A2Homo sapiens (human)
calcium ion bindingAnnexin A2Homo sapiens (human)
protein bindingAnnexin A2Homo sapiens (human)
calcium-dependent phospholipid bindingAnnexin A2Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingAnnexin A2Homo sapiens (human)
cytoskeletal protein bindingAnnexin A2Homo sapiens (human)
phospholipase A2 inhibitor activityAnnexin A2Homo sapiens (human)
identical protein bindingAnnexin A2Homo sapiens (human)
S100 protein bindingAnnexin A2Homo sapiens (human)
calcium-dependent protein bindingAnnexin A2Homo sapiens (human)
cadherin binding involved in cell-cell adhesionAnnexin A2Homo sapiens (human)
phosphatidylserine bindingAnnexin A2Homo sapiens (human)
lipid bindingProtein S100-A10Homo sapiens (human)
protein bindingProtein S100-A10Homo sapiens (human)
protein homodimerization activityProtein S100-A10Homo sapiens (human)
transmembrane transporter bindingProtein S100-A10Homo sapiens (human)
calcium-dependent protein bindingProtein S100-A10Homo sapiens (human)
calcium ion bindingProtein S100-A10Homo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (40)

Processvia Protein(s)Taxonomy
membrane raftAnnexin A2Homo sapiens (human)
collagen-containing extracellular matrixAnnexin A2Homo sapiens (human)
cornified envelopeAnnexin A2Homo sapiens (human)
extracellular regionAnnexin A2Homo sapiens (human)
basement membraneAnnexin A2Homo sapiens (human)
extracellular spaceAnnexin A2Homo sapiens (human)
nucleusAnnexin A2Homo sapiens (human)
cytoplasmAnnexin A2Homo sapiens (human)
lysosomal membraneAnnexin A2Homo sapiens (human)
endosomeAnnexin A2Homo sapiens (human)
early endosomeAnnexin A2Homo sapiens (human)
lipid dropletAnnexin A2Homo sapiens (human)
cytosolAnnexin A2Homo sapiens (human)
plasma membraneAnnexin A2Homo sapiens (human)
adherens junctionAnnexin A2Homo sapiens (human)
cell surfaceAnnexin A2Homo sapiens (human)
membraneAnnexin A2Homo sapiens (human)
basolateral plasma membraneAnnexin A2Homo sapiens (human)
nuclear matrixAnnexin A2Homo sapiens (human)
midbodyAnnexin A2Homo sapiens (human)
late endosome membraneAnnexin A2Homo sapiens (human)
vesicleAnnexin A2Homo sapiens (human)
azurophil granule lumenAnnexin A2Homo sapiens (human)
myelin sheath adaxonal regionAnnexin A2Homo sapiens (human)
sarcolemmaAnnexin A2Homo sapiens (human)
melanosomeAnnexin A2Homo sapiens (human)
Schmidt-Lanterman incisureAnnexin A2Homo sapiens (human)
collagen-containing extracellular matrixAnnexin A2Homo sapiens (human)
extracellular exosomeAnnexin A2Homo sapiens (human)
RNA polymerase II transcription regulator complexAnnexin A2Homo sapiens (human)
plasma membrane protein complexAnnexin A2Homo sapiens (human)
PCSK9-AnxA2 complexAnnexin A2Homo sapiens (human)
AnxA2-p11 complexAnnexin A2Homo sapiens (human)
cytoplasmAnnexin A2Homo sapiens (human)
nucleusAnnexin A2Homo sapiens (human)
plasma membraneAnnexin A2Homo sapiens (human)
vesicle membraneAnnexin A2Homo sapiens (human)
membrane raftProtein S100-A10Homo sapiens (human)
extracellular regionProtein S100-A10Homo sapiens (human)
plasma membraneProtein S100-A10Homo sapiens (human)
cell surfaceProtein S100-A10Homo sapiens (human)
nuclear matrixProtein S100-A10Homo sapiens (human)
collagen-containing extracellular matrixProtein S100-A10Homo sapiens (human)
extracellular exosomeProtein S100-A10Homo sapiens (human)
RNA polymerase II transcription regulator complexProtein S100-A10Homo sapiens (human)
plasma membrane protein complexProtein S100-A10Homo sapiens (human)
AnxA2-p11 complexProtein S100-A10Homo sapiens (human)
extracellular spaceProtein S100-A10Homo sapiens (human)
cytoplasmProtein S100-A10Homo sapiens (human)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1162040Inhibition of Annexin A2 N-terminus/Protein S100-A10 (unknown origin) protein interaction pre-incubated for 5 mins by FRET assay2014Bioorganic & medicinal chemistry, Oct-01, Volume: 22, Issue:19
Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]